检索结果-南通市图书馆

Impact of hyperthermic intraperitoneal chemotherapy on gastric cancer survival: peritoneal metastasis and cytology perspectives

引用

World Journal of Clinical Oncology 2024年第7期15卷 840-847页

作者： Asada Methasate Thammawat Parakonthun Thita Intralawan Chawisa Nampoolsuksan Jirawat Swangsri Minimally Invasive Surgery Unit Department of SurgeryFaculty of Medicine Siriraj HospitalMahidol UniversityBangkok 10700Thailand Upper Gastrointestinal Cancer Center Siriraj Hospital Mahidol UniversityBangkok 10700Thailand

BACKGROUND Gastric cancer presenting with peritoneal metastasis is notably associated with diminished survival *** use of cytoreductive surgery in conjunction with hyperthermic intraperitoneal chemotherapy(HIPEC)has been shown to increase survival rates in these *** these advancements,debates persist regarding the magnitude of survival improvement attributed to this treatment *** present investigation examined survival outcomes following HIPEC in individuals diagnosed with gastric cancer and peritoneal metastasis,and it took a comparative analysis of patients exhibiting positive and negative cytological *** April 2013 and March 2020,84 patients with advanced gastric cancer treated at our institution were categorized into three cohorts:HIPEC(20 patients with peritoneal metastasis),cytology-positive(23 patients without peritoneal nodules but with positive wash cytology),and cytology-negative(41 patients with advanced gastric cancer,no peritoneal nodules,and negative wash cytology).The HIPEC cohort underwent gastrectomy with HIPEC,while the cytology-positive and cytology-negative groups received gastrectomy *** demographic,pat-hological,and survival data of the groups were *** The HIPEC cohort-predominantly younger females-exhibited relatively extended surgical durations and high blood ***,the complication rates were consistent across all three *** survival in the HIPEC group was 20.00±4.89 months,with 1-year,2-year,and 3-year overall survival rates of 73.90%,28.70%,and 9.60%,*** figures paralleled the survival rates of the cytology-positive group(52.20%at 1 year,28.50%at 2 years,and 19.00%at 3 years).Notably,47%of patients experienced peritoneal *** HIPEC may offer a modest improvement in short-term survival for patients with gastric cancer and peritoneal metastasis,mirroring the outcomes in cytology-positive ***,peritoneal recurrence r

关键词： Cytoreductive surgery Gastric cancer Hyperthermic intraperitoneal chemotherapy peritoneal metastasis Positive cytology

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Effect of BRAF mutation on the prognosis for patients with colorectal cancer undergoing cytoreductive surgery for synchronous peritoneal metastasis

引用

Gastroenterology Report 2023年第1期11卷 492-499页

作者： Zhijie Wu Xiusen Qin Yuanxin Zhang Jian Luo Rui Luo Zonglu Cai Hui Wang Department of General Surgery(Colorectal Surgery) The Sixth Affiliated HospitalSun Yat-sen UniversityGuangzhouGuangdongP.R.China Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases The Sixth Affiliated HospitalSun Yat-sen UniversityGuangzhouGuangdongP.R.China Biomedical Innovation Center The Sixth Affiliated HospitalSun Yat-sen UniversityGuangzhouGuangdongP.R.China

Background:KRAS/BRAF mutations(mutKRAS/mutBRAF)are unfavorable prognostic factors for colorectal cancer(CRC)metastases to the liver and ***,their effects on the prognosis for patients with synchronous peritoneal metastasis(S-PM)of CRC after cytoreductive surgery(CRS)and hyperthermic intraperitoneal chemotherapy(HIPEC)are *** the study,we aimed to determine the effects of mutKRAS/mutBRAF on the prognosis for patients with S-PM who received ***:A total of 142 patients diagnosed with S-PM between July 2007 and July 2019 were included in this *** demographics,mutKRAS/mutBRAF status,overall survival(OS),and progression-free survival(PFS)of the patients were *** Kaplan–Meier method and log-rank test were used to estimate the difference in survival between ***:Among 142 patients,68(47.9%)showed mutKRAS and 42(29.5%)showed *** median OS values were 8.4 and 34.3 months for patients with mutBRAF and BRAF wild-type,respectively(P<0.01).However,KRAS status was not significantly associated with median OS(P=0.76).Multivariate analysis revealed carcinoembryonic antigen,CRS,HIPEC,and mutBRAF as independent predictors for *** on these findings,a nomogram was *** C-index was 0.789(95%confidence interval,0.742–0.836),indicating good predictive ability of the ***,the 1-and 2-year survival calibration plots showed good agreement between the predicted and actual OS *** area under curves of the 1-and 2-year survival predictions based on the nomogram were 0.807 and 0.682,***,mutBRAF was significantly associated with lower PFS(P<0.001).Conclusions:mutBRAF is an independent prognostic risk factor for *** established nomogram predicted the OS of patients with CRC having S-PM with high accuracy,indicating its usefulness as a valuable prognostic tool for the designated patient cohort.

关键词： colorectal cancer peritoneal metastasis BRAF prognosis

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

HAND2-AS1,PRKAA2 and VLDLR predict the risk of peritoneal metastasis in gastric cancer of different Lauren types based on STEPP analysis

引用

BIOCELL 2022年第3期46卷 721-735页

作者： HUI QU RUICHUAN SHI BOWEN YANG XI CHEN YUJIA SONG LINGZI HE YITING SUN YUJING YANG ZHI LI XIUJUAN QU Department of Medical Oncology The First Hospital of China Medical UniversityShenyang110001China Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province The First Hospital of China Medical UniversityShenyang110001China Liaoning Province Clinical Research Center for Cancer Shenyang110001China Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors Ministry of EducationShenyang110001China

The peritoneum is the most common site of recurrence of gastric cancer(GC).Early occult peritoneal metastasis is difficult to detect by imaging *** the risk of peritoneal metastasis in patients with different Lauren subtypes is of great clinical *** performed a univariate Cox regression to identify those genes with prognostic value of overall survival(OS)and peritoneal-specified disease-free survival(psDFS)from the Gene Expression Omnibus *** candidate genes were screened by the Subpopulation Treatment Effect Pattern Plot(STEPP)*** score matching(PSM)analysis was used to reduce the interference of confounders on the *** on the optimal cut-off values determined by the STEPP method,we found overexpression of three genes(HAND2-AS1,PRKAA2,and VLDLR)was correlated with shorter 1-year psDFS among patients with diffuse-type than that of patients with intestinal-type GC,and it is highly *** Set Enrichment Analysis(GSEA)potentially suggested that the three genes promote the early occurrence of peritoneal metastasis in patients with diffuse-type GC through glucose metabolism-related *** three genes may be potential *** can be used to assess the risk of peritoneal metastases to guide treatment decisions and follow-up strategies.

关键词： peritoneal metastasis Gastric cancer Lauren STEPP

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Can visceral fat parameters based on computed tomography be used to predict occult peritoneal metastasis in gastric cancer?

引用

World Journal of Gastroenterology 2023年第15期29卷 2310-2321页

作者： Li-Ming Li Lei-Yu Feng Chen-Chen Liu Wen-Peng Huang Yang Yu Peng-Yun Cheng Jian-Bo Gao Department of Radiology Henan Key Laboratory of Imaging Diagnosis and Treatment for Digestive system TumorThe First Affiliated Hospital of Zhengzhou UniversityZhengzhou 450052Henan ProvinceChina Department of Cardiology The First Affiliated Hospital of Zhengzhou UniversityZhengzhou 450052Henan ProvinceChina Department of Radiology The First Affiliated Hospital of Zhengzhou UniversityZhengzhou 450052Henan ProvinceChina Department of Nuclear Medicine Peking University First HospitalBeijing 100034China Beijing Branch Siemens Healthineers Ltd.Shenyang 110011Liaoning ProvinceChina

BACKGROUND The preoperative prediction of peritoneal metastasis(PM)in gastric cancer would prevent unnecessary surgery and promptly indicate an appropriate treatment *** To explore the predictive value of visceral fat(VF)parameters obtained from preoperative computed tomography(CT)images for occult PM and to develop an individualized model for predicting occult PM in patients with gastric carcinoma(GC).METHODS A total of 128 confirmed GC cases(84 male and 44 female patients)that underwent CT scans were analyzed and categorized into PM-positive(n=43)and PM-negative(n=85)*** clinical characteristics and VF parameters of two regions of interest(ROIs)were *** and stratified analyses based on VF volume were performed to screen for predictive characteristics for occult *** models with and without VF parameters were established by multivariable logistic regression *** The mean attenuations of VF_(ROI 1)and VF_(ROI 2)varied significantly between the PM-positive and PMnegative groups(P=0.044 and 0.001,respectively).The areas under the receiver operating characteristic curves(AUCs)of VF_(ROI 1)and VF_(ROI 2)were 0.599 and 0.657,*** mean attenuation of VF_(ROI 2)was included in the final prediction combined model,but not an independent risk factor of PM(P=0.068).No significant difference was observed between the models with and without mean attenuation of VF(AUC:0.749 vs 0.730,P=0.339).CONCLUSION The mean attenuation of VF is a potential auxiliary parameter for predicting occult PM in patients with GC.

关键词： Gastric carcinoma peritoneal metastasis Visceral fat Tomography X-ray computed Prediction Individualized model

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis

引用

Chinese Journal of Cancer Research 2020年第4期32卷 497-507页

作者： Zhongyin Yang Chen Li Wentao Liu Yanan Zheng Zhenglun Zhu Ziehen Hua Zhentian Ni Sheng Lu Min Yan Chao Yan Zhenggang Zhu Department of General Surgery Gastrointestinal SurgeryShanghai Key Laboratory of Gastric NeoplasmsShanghai Institute of Digestive SurgeryRuijin HospitalShanghai Jiao Tong University School of MedicineShanghai 200025China

Objective:Intraperitoneal(IP)chemotherapy through subcutaneous port is an effective treatment for gastric cancer(GC)patients with peritoneal metastasis(PM).The objective of this study is to assess the port complications and risk factors for complications in GC patients with ***:In retrospective screening of 301 patients with subcutaneous ports implantation,249 GC patients with PM who received IP chemotherapy were screened out for *** complications and risk factors for complications were ***:Of the 249 analyzed patients,57(22.9%)experienced port *** liquid accumulation(42.1%)and infection(28.1%)were the main complications,and other complications included port rotation(14.1%),wound dehiscence(12.3%),inflow obstruction(1.7%)and subcutaneous metastasis(1.7%).The median interval between port implantation and occurrence of complications was 3.0 *** Cooperative Oncology Group(ECOG)performance status[odds ratio(OR),1.74;95%confidence interval(95%CI),1.12-2.69],albumin(OR,3.67;95%CI,1.96-6.86),implantation procedure optimization(OR,0.33;95%CI,0.18-0.61)and implantation groups(OR,0.37;95%CI,0.20-0.69)were independent risk factors for port complications(P<0.05).ECOG performance status was the only factor that related to the grades of port complications(P=0.016).Conclusions:Port complications in GC patients who received IP chemotherapy are *** performance status,albumin,implantation procedure and implantation group are independent risk factors for port complications in GC patients with PM.

关键词： Gastric cancer peritoneal metastasis intraperitoneal chemotherapy paclitaxel port complication

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis

引用

World Journal of Gastroenterology 2017年第42期23卷 7541-7550页

作者： Akiharu Kimura Kyoichi Ogata Bolag Altan Takehiko Yokobori Erito Mochiki Mitsuhiro Yanai Norimichi Kogure Toru Yanoma Masaki Suzuki Tuya Bai Hiroyuki Kuwano Department of General Surgical Science Gunma University Graduate School of Medicine Department of Oncology Clinical Development Gunma University Graduate School of Medicine Department of Molecular Pharmacology and Oncology Gunma University Graduate School of Medicine Department of Digestive Tract and General Surgery Saitama Medical CenterSaitama Medical University

AIM To investigate the significance of heat shock protein 110(HSP110) in gastric cancer(GC) patients with peritoneal metastasis undergoing *** Primary GC patients(n = 14) with peritoneal metastasis or positive peritoneal lavage cytology who underwent distal or total gastrectomy between April 2000 and December 2011 were enrolled in this study. The patients underwent postoperative intraperitoneal hyperthermo-chemotherapy using a Thermotron RF-8 heating device two weeks after surgery. We analyzed nuclear HSP110 expression in surgically resected tumors using immunohistochemistry. Additionally, the effect of HSP110 suppression on hyptherthermochemosensitivity was assessed in vitro in the MKN45 GC cell line using the HSP inhibitor KNK437. RESULTS HSP110 immnohistochemical staining in 14 GC patients showed that five(35.7%) samples belonged to the low expression group, and nine(64.3%) samples belonged to the high expression group. Progression-free survival was significantly shorter in the HSP110 high-expression group than in the low-expression group(P = 0.0313). However, no significant relationships were identified between HSP110 expression and the clinicopathological characteristics of patients. Furthermore, high HSP110 expression was not an independent prognostic factor in GC patients with peritoneal metastasis(P = 0.0625). HSP110 expression in MKN45 cells was suppressed by KNK437 at the hyperthermic temperature of 43 ℃ in vitro. Comparison of MKN45 cell proliferation in the presence and absence of KNK437 at 43 ℃, revealed that proliferation was significantly decreased when HSP110 was inhibited by KNK437. Additionally, HSP110 suppression via HSP inhibitor treatment increased cellular sensitivity to hyperthermo-chemotherapy in *** The expression of nuclear HSP110 in GC patients might be a new marker of chemosensitivity and a therapeutic target for patients who are tolerant to existing hyperthermo-chemotherapies.

关键词： peritoneal metastasis Hyperthermia Hyperthermo-chemotherapy Heat shock protein 110 Gastric cancer Drug resistance

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis:A multicenter propensity scorematched cohort study

引用

Chinese Journal of Cancer Research 2020年第6期32卷 794-803页

作者： Ziying Lei Jiahong Wang Zhi Li Baozhong Li Jiali Luo Xuejun Wang Jin Wang MingchenBa Hongsheng Tang Qingjun He Quanxing Liao Xiansheng Yang Tianpei Guan Han Liang Shuzhong Cui Department of Abdominal Surgery Affiliated Cancer Hospital&Institute of Guangzhou Medical UniversityGuangzhou 510095China Department of General Surgery Affiliated Tumor Hospital of Zhengzhou UniversityTumor Hospital of Henan ProvinceZhengzhou 450008China Department of Surgery Anyang Tumor HospitalAnyang 455000China Department of Oncology Guangzhou Medical UniversityGuangzhou 510095China Department of Gastrointestinal Cancer Tianjin Medical University Cancer Institute&HospitalNational Clinical Research Center of CancerKey Laboratory of Cancer Prevention and TherapyTianjin's Clinical Research Center for CancerTianjin 300060China

Objective:Systemic chemotherapy has limited efficacy in the treatment of peritoneal metastasis(PM)in gastric cancer(GC).Hyperthermic intraperitoneal chemotherapy(HIPEC)combined with complete cytoreductive surgery(CRS)has shown promising outcomes but remains *** present study aimed to evaluate the safety and efficacy of HIPEC without CRS in GC patients with ***:This retrospective propensity score-matched multicenter cohort study included GC patients with PM treated with either chemotherapy alone(Cx group)or with HIPEC combined with chemotherapy(HIPEC-Cx group)in four Chinese high-volume gastric medical centers between 2010 and *** primary outcomes were median survival time(MST)and 3-year overall survival(OS).Propensity score matching was performed to compensate for controlling potential confounding effects and selection ***:Of 663 eligible patients,498 were *** MST in the Cx and HIPEC-Cx groups was 10.8 and 15.9 months,respectively[hazard ratio(HR)=0.71,95%confidence interval(95%CI),0.58-0.88;P=0.002].The 3-year OS rate was 10.1%(95%CI,5.4%-14.8%)and 18.4%(95%CI,12.3%-24.5%)in the Cx and HIPEC-Cx groups,respectively(P=0.017).The complication rates were *** time to first flatus and length of hospital stay for patients undergoing HIPEC combined with chemotherapy was longer than that of chemotherapy alone(4.6±2.4 d vs.2.7±1.8 d,P<0.001;14.2±5.8 d vs.11.4±7.7 d,P<0.001),*** median follow-up period was 33.2 ***:Compared with standard systemic chemotherapy,HIPEC combined with chemotherapy revealed a statistically significant survival benefit for GC patients with PM,without compromising patient safety.

关键词： Gastric cancer peritoneal metastasis hyperthermic intraperitoneal chemotherapy chemotherapy

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Solitary peritoneal metastasis of gastrointestinal stromal tumor: A case report

引用

World Journal of Gastroenterology 2020年第36期26卷 5527-5533页

作者： Yoichi Sugiyama Kensuke Shimbara Masaru Sasaki Mohei Kouyama Tatsuya Tazaki Shinya Takahashi Atsushi Nakamitsu Department of Gastrointestinal Surgery JA Hiroshima General HospitalHatsukaichi 738-8503Japan Department of Surgery Institute of Biomedical and Health SciencesHiroshima UniversityHiroshima 734-8551Japan

BACKGROUND A gastrointestinal stromal tumor(GIST)is a mesenchymal tumor of the gastrointestinal tract that is most commonly found in the *** of GISTs mostly occurs in the liver or peritoneum,and in most cases,multiple metastases *** a solitary peritoneal metastasis is rare,an appropriate treatment strategy has not been ***,we report a case of solitary peritoneal metastasis after complete resection of gastric *** SUMMARY A 76-year-old woman was diagnosed with stomach GIST and underwent laparoscopic local resection using the CLEAN-NET *** the recurrence risk was intermediate,adjuvant imatinib therapy was not *** years after surgery,routine computed tomography revealed an abdominal mass between the dorsal side of the right hepatic lobe and right *** imaging tests did not reveal any *** observation showed that the tumor was located at the retroperitoneum,and intraperitoneal dissemination was not ***,we performed laparoscopic tumor ***,the tumor was positive for c-kit and CD34 and had a relatively high mitotic index and MIB-1 Labeling *** administered adjuvant imatinib *** was no evidence of recurrence 3 years after the *** This is the first reported case of a solitary recurrence of GIST in the peritoneum treated with complete laparoscopic resection.

关键词： Gastrointestinal stromal tumor peritoneal metastasis Laparoscopic resection Solitary metastasis Imatinib Case report

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

CYS1 Promotes peritoneal metastasis via Inhibiting the Formation of E-cadherin/β-catenin Complex by Binding PHB2 in Gastric Cancer

CYS1 Promotes Peritoneal Metastasis via Inhibiting the Forma...

引用

2021年中国肿瘤标志物学术大会暨第十五届肿瘤标志物青年科学家论坛

作者： Hongfei Yan Xiaofang Che Yunpeng Liu Xiujuan Qu Department of Medical Oncology The First Hospital of China Medical University Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province The First Hospital of China Medical University Liaoning Province Clinical Research Center for Cancer the First Hospital of China Medical University Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors Ministry of Education the First Hospital of China Medical University

Background: Peritoneum is the most common metastatic site in advanced gastric cancer(GC), which shortens the survival of GC patients and lacks effective treatment. It is of great significance for early diagnosis of peritoneal metastasis and looking for new treatment strategies that screening the key oncogenes in gastric cancer peritoneal metastasis and clarifying their novel ***: This study aims to explore the ability of prognostic prediction of CYS1 in GC and clarify the underlying mechanisms of CYS1 in facilitating peritoneal metastasis(PM) in ***: The Cancer Genome Atlas(TCGA) and Gene Expression Omnibus(GEO) databases were used to analyze PM-related genes and the association between CYS1 expression and prognosis in *** was performed to detect the expression of CYS1 in tumor and normal tissues of GC patients. Quantitative real-time polymerase chain reaction and western blots were applied to examine the expression of CYS1 in GC cell lines and expression of genes in downstream *** role of CYS1 on the adhesion between GC cells was explored with the hanging drop assay. The effect of CYS1 on the adhesion between GC cells and peritoneal mesothelial cells(PMC) was performed by the adhesion assay. The role of CYS1 on the migration and invasion of GC cell lines was investigated with the transwell assay. Mass spectrometry(MS) was used to detect the proteins binding with CYS1 in GC cells. GST-pull down assay was carried out to verify the binding motifs in vitro. Nuclear and cytosol fractionation assay and immunofluorescence assay exhibited the distribution of β-catenin. Orthotopic mouse model of GC demonstrated the effect of CYS1 on peritoneal metastasis of ***: 1. CYS1 is associated with peritoneal metastasis of GC. By using TCGA and GSE62254 datasets,we screened 804 genes related to poor prognosis in GC. Among them, by comparing genes in different metastatic sites, we finally found 59 genes whose expression was hig

关键词： CYS1 gastric cancer E-ca/β-catenin PHB2 peritoneal metastasis

来源： cnki会议评论

在线全文

cnki会议

学校读者我要写书评

暂无评论

Prognostic factors of early recurrence after complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

引用

World Journal of Clinical Cases 2024年第27期12卷 6057-6069页

作者： Chao-Yu Chen Tzu-Hao Huang Li-Wen Lee Jrhau Lung Yu-Che Ou Chien-Hui Hung Huei-Chieh Chuang Min-Chi Chen Ting-Yao Wang Department of Obstetrics and Gynecology Chang Gung Memorial HospitalChiayi 613Taiwan Graduate Institute of Clinical Medical Sciences College of MedicineChang Gung UniversityTaoyuan 333Taiwan Department of Early Childhood Care and Education Shu-Zen Junior College of Medicine and ManagementKaohsiung 821Taiwan Division of General Surgery Department of SurgeryChang Gung Memorial HospitalChiayi 613Taiwan Department of Diagnostic Radiology Chang Gung Memorial HospitalChiayi 613Taiwan College of Medicine Chang Gung UniversityTaoyuan 333Taiwan Department of Medical Research and Development Chang Gung Memorial HospitalChiayi 613Taiwan Department of Obstetrics and Gynecology Kaohsiung Chang Gung Memorial HospitalKaohsiung 833Taiwan Department of Anatomic Pathology Chang Gung Memorial HospitalChiayi 613Taiwan Department of Public Health Chang Gung UniversityTaoyuan 333Taiwan Division of Hematology and Oncology Department of Internal MedicineChang Gung Memorial HospitalChiayi 613Taiwan

BACKGROUND Although cytoreductive surgery(CRS)and hyperthermic intraperitoneal chemotherapy(HIPEC)offer the potential for long-term survival in peritoneal carcinomatosis,outcomes following CRS/HIPEC vary *** To identify the clinical factors associated with progression-free survival(PFS)after complete CRS/HIPEC in patients with colorectal/high-grade appendiceal,ovarian,and gastric *** We retrospectively evaluated the risk of recurrence within 1 year after CRS/HIPEC and its impact on overall survival(OS)in patients recruited between 2015 and *** regression models were used to assess the prognostic factors for the risk of recurrence within 1 ***–Meier survival curves and Cox proportional hazards models were used to evaluate the association between recurrence and *** Of the 80 enrolled patients,39 had an unfavorable PFS(peritoneal cancer index score>12 was associated with a lower rate of achieving CC-0(P=0.027).The favorable PFS group had a significantly longer OS(median 81.7 mo vs 17.0 mo,Pperitoneal carcinomatosis.

关键词： peritoneal metastasis Cytoreductive surgery Hyperthermic intraperitoneal chemotherapy Predictor Recurrence

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：